Literature DB >> 15188348

Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity.

Maarten Boers1, Ben Dijkmans, Sherine Gabriel, Hilal Maradit-Kremers, James O'Dell, Theodore Pincus.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15188348     DOI： 10.1002/art.20306

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  28 in total

1.  Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases.

Authors:  Laura R Rekedal; Elena Massarotti; Rajesh Garg; Radhika Bhatia; Timothy Gleeson; Bing Lu; Daniel H Solomon
Journal:  Arthritis Rheum       Date:  2010-12

Review 2.  Perception of risk: the state of COX-2 selective inhibitors.

Authors:  Lee S Simon; Vibeke Strand
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

Review 3.  A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis.

Authors:  Eduardo Nicolas Pollono; Maria A Lopez-Olivo; Juan Antonio Martinez Lopez; Maria E Suarez-Almazor
Journal:  Clin Rheumatol       Date:  2010-04-10       Impact factor: 2.980

4.  High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.

Authors:  Christina Charles-Schoeman; David Meriwether; Yuen Yin Lee; Ani Shahbazian; Srinivasa T Reddy
Journal:  Clin Rheumatol       Date:  2017-11-11       Impact factor: 2.980

5.  Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis.

Authors:  Cecilia P Chung; Jon T Giles; Michelle Petri; Moyses Szklo; Wendy Post; Roger S Blumenthal; Allan C Gelber; Pamela Ouyang; Nancy S Jenny; Joan M Bathon
Journal:  Semin Arthritis Rheum       Date:  2012-02       Impact factor: 5.532

6.  Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis.

Authors:  L Björnådal; L Brandt; L Klareskog; J Askling
Journal:  Ann Rheum Dis       Date:  2005-10-25       Impact factor: 19.103

7.  Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis.

Authors:  Anna Södergren; Birgitta Stegmayr; Vivan Lundberg; Marie-Louise Ohman; Solveig Wållberg-Jonsson
Journal:  Ann Rheum Dis       Date:  2006-07-19       Impact factor: 19.103

8.  Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.

Authors:  Calin Popa; Frank H J van den Hoogen; Timothy R D J Radstake; Mihai G Netea; Agnes E Eijsbouts; Martin den Heijer; Jos W M van der Meer; Piet L C M van Riel; Anton F H Stalenhoef; Pilar Barrera
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

Review 9.  Outcome measures in inflammatory rheumatic diseases.

Authors:  Jaap Fransen; Piet L C M van Riel
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

10.  The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?

Authors:  Michael M Ward
Journal:  F1000 Med Rep       Date:  2009-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.